neostigmine has been researched along with Decerebrate Posturing in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherki-Vakil, R | 1 |
| Ginsburg, S | 1 |
| Meiri, H | 1 |
| Kirsten, EB | 1 |
| Schoener, EP | 1 |
2 other studies available for neostigmine and Decerebrate Posturing
| Article | Year |
|---|---|
The difference in shape of spontaneous and uniquantal evoked synaptic potentials in frog muscle.
Topics: Acetylcholinesterase; Animals; Decerebrate State; Evoked Potentials; In Vitro Techniques; Membrane P | 1995 |
Action of anticholinergic and related agents on single vestibular neurones.
Topics: Alkaloids; Animals; Atropa belladonna; Atropine; Blood Pressure; Cats; Decerebrate State; Diphenhydr | 1973 |